ICH Q3E
IMPURITY: Assessment and Control of Extractables and Leachables for Pharmaceuticals and Biologics
This topic was endorsed by the ICH Assembly in June 2019, and an informal Working Group is being established to develop a Concept Paper and Business Plan.
informal WG Lead: Dr. Ingrid Markovic (PhRMA)
Regulatory Chair: Dr. Jason Rodriguez (FDA, United States)